Cargando…
Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial
BACKGROUND: Young male cancer survivors have lower testosterone levels, higher fat mass, and worse quality of life (QoL) than age-matched healthy controls. Low testosterone in cancer survivors can be due to orchidectomy or effects of chemotherapy and radiotherapy. We have undertaken a double-blind,...
Autores principales: | Walsh, Jennifer S., Marshall, Helen, Smith, Isabelle L., Greenfield, Diana M., Swain, Jayne, Best, Emma, Ashton, James, Brown, Julia M., Huddart, Robert, Coleman, Robert E., Snowden, John A., Ross, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850530/ https://www.ncbi.nlm.nih.gov/pubmed/31714912 http://dx.doi.org/10.1371/journal.pmed.1002960 |
Ejemplares similares
-
Testosterone replacement in young male cancer survivors (TRYMS) - pragmatic adaptation of trial design for a trial struggling with recruitment
por: Smith, Isabelle, et al.
Publicado: (2015) -
TRYMS: the ethical and practical considerations of a double-blind placebo controlled randomised clinical trial
por: Swain, Jayne, et al.
Publicado: (2015) -
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
por: Bandak, Mikkel, et al.
Publicado: (2017) -
Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015) -
Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)